PCSK9 inhibitors are a breakthrough injectable therapy that dramatically lowers cholesterol when statins aren’t enough.

ApoB measurement revolutionizes cardiovascular risk assessment by counting atherogenic particles and guiding therapies like PCSK9 inhibitors.

Lp(a), a blood particle linked to heart disease risk, can’t be reliably lowered by standard treatments. Testing is simple and knowing your level guides care.

Statins effectively prevent heart attacks in most people, but genetic differences mean some patients need alternative approaches to managing cardiovascular risk.

Natto, a traditional Japanese fermented soybean food, shows promising cardiovascular benefits backed by both cultural wisdom and recent research.

Explore key imaging tools for early heart disease detection, from CAC scoring to PET scans, with insights on costs and benefits.